wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-355688E7-89AC-4D76-B9A1-94E4CCABEDAC
Q38404422-355688E7-89AC-4D76-B9A1-94E4CCABEDAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-355688E7-89AC-4D76-B9A1-94E4CCABEDAC
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-355688E7-89AC-4D76-B9A1-94E4CCABEDAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-355688E7-89AC-4D76-B9A1-94E4CCABEDAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.